UBS Oconnor LLC
- SEC CIK
- 0001132716
- Latest filing
- Aug 14, 2026
VRNA holding history
Verona Pharma plc in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRNA overviewAll 13F holders of VRNAFull Q4 2025 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −4,283,462−100.0% | Sold out | Holders |
| Q3 2025 | 4,283,462 | $457.1M | 13.7% | +4,283,462 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −17,150−100.0% | Sold out | Holders |
| Q1 2025 | 17,150 | $1.09M | <0.1% | +17,150 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −22,541−100.0% | Sold out | Holders |
| Q3 2024 | 22,541 | $648.5K | <0.1% | +22,541 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −36,305−100.0% | Sold out | Holders |
| Q1 2024 | 36,305 | $584.1K | <0.1% | −12,228−25.2% | Reduced | Holders |
| Q4 2023 | 48,533 | $964.8K | <0.1% | −39,095−44.6% | Reduced | Holders |
| Q3 2023 | 87,628 | $1.43M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 87,628 | $1.85M | <0.1% | −9,944−10.2% | Reduced | Holders |
| Q1 2023 | 97,572 | $1.96M | <0.1% | +97,572 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −111,926−100.0% | Sold out | Holders |
| Q3 2022 | 111,926 | $1.14M | <0.1% | +111,926 | New | Holders |